Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 17, 2024
Targeting macrophagic RasGRP1 with catechin hydrate ameliorates sepsis-induced multiorgan dysfunctionZhixi Li, Yongjing Yu, Yue Bu, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|December 19, 2023
[Selection and validation of reference genes for quantitative real-time PCR analysis in Paeonia veitchii]Meng-Ting Luo, Jun-Zhang Qubie, Ming-Kang Feng, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 30, 2025
Retinal alterations induced by amyotrophic lateral sclerosis: An analysis using optical coherence tomographyYue Bu, Yanchun Yuan, Fan Hu, et al.
Brain and Behavior|May 19, 2025
Shape Alterations of Subcortical Nuclei Correlate With Amyotrophic Lateral Sclerosis ProgressionYanchun Yuan, Yan Fu, Xueying Wang, et al.
Fitoterapia|April 21, 2025
Eight new triterpenoid saponins from the leaves of Astragalus membranaceus (Fisch.) Bunge and their neuroprotective effectsWen-Xiang Xu, Zhen-Yun Liu, Qing-Yue Bu, et al.
Critical Care (London, England)|August 31, 2021
Identification of distinct clinical phenotypes of acute respiratory distress syndrome with differential responses to treatmentXiaowei Liu, Yusheng Jiang, Xiaonan Jia, et al.
Nature Communications|September 27, 2024
Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trialDalong Zhu, Weimin Wang, Guoyu Tong, et al.
The Lancet. Diabetes & Endocrinology|August 25, 2025
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trialYang He, Nianrong Mi, Zhifeng Cheng, et al.
Nature Communications|January 7, 2026
Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a multi-centre, randomised, double-blind, placebo-controlled, phase 3 trialDalong Zhu, Weimin Wang, Guoyu Tong, et al.
Pageof 4